BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 24983265)

  • 1. Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure.
    Kop WJ; Gottdiener JS; deFilippi CR; Barasch E; Seliger SL; Jenny NS; Christenson RH
    Circ Heart Fail; 2012 Jul; 5(4):406-13. PubMed ID: 22685114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort.
    Kobayashi M; Ferreira JP; Duarte K; Bresso E; Huttin O; Bozec E; Brunner La Rocca HP; Delles C; Clark AL; Edelmann F; González A; Heymans S; Pellicori P; Petutschnigg J; Verdonschot JAJ; Rossignol P; Cleland JGF; Zannad F; Girerd N;
    Eur J Heart Fail; 2024 May; 26(5):1231-1241. PubMed ID: 38528728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study.
    Barasch E; Gottdiener JS; Aurigemma G; Kitzman DW; Han J; Kop WJ; Tracy RP
    Circ Heart Fail; 2011 Nov; 4(6):733-9. PubMed ID: 21900186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
    Aguiar P; Azevedo O; Pinto R; Marino J; Cardoso C; Sousa N; Cunha D; Hughes D; Ducla Soares JL
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.
    Yu YL; Siwy J; An DW; González A; Hansen T; Latosinska A; Pellicori P; Ravassa S; Mariottoni B; Verdonschot JA; Ahmed F; Petutschnigg J; Rossignol P; Heymans S; Cuthbert JJ; Girerd N; Clark AL; Verhamme P; Nawrot TS; Janssens S; Cleland JG; Zannad F; Diez J; Mischak H; Ferreira JP; Staessen JA;
    Heart; 2024 May; ():. PubMed ID: 38729636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multi-biomarker approach for heart failure in patients with hypertension.
    Bielecka-Dabrowa A; Gluba-Brzózka A; Michalska-Kasiczak M; Misztal M; Rysz J; Banach M
    Int J Mol Sci; 2015 May; 16(5):10715-33. PubMed ID: 25984599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in collagen metabolism account for ventricular functional recovery following beta-blocker therapy in patients with chronic heart failure.
    Fukui M; Goda A; Komamura K; Nakabo A; Masaki M; Yoshida C; Hirotani S; Lee-Kawabata M; Tsujino T; Mano T; Masuyama T
    Heart Vessels; 2016 Feb; 31(2):173-82. PubMed ID: 25351137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review.
    Nikolov A; Popovski N
    Metabolites; 2022 Mar; 12(4):. PubMed ID: 35448484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.
    Koniari I; Artopoulou E; Velissaris D; Ainslie M; Mplani V; Karavasili G; Kounis N; Tsigkas G
    J Geriatr Cardiol; 2021 Nov; 18(11):908-951. PubMed ID: 34908928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Biomarkers in Heart Failure: New Insight in Pathophysiology and Clinical Perspective.
    Biasucci LM; Maino A; Grimaldi MC; Cappannoli L; Aspromonte N
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study.
    Ekström M; Hellman A; Hasselström J; Hage C; Kahan T; Ugander M; Wallén H; Persson H; Linde C
    ESC Heart Fail; 2020 Apr; 7(2):737-746. PubMed ID: 32073753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure.
    Zhang ZY; Ravassa S; Nkuipou-Kenfack E; Yang WY; Kerr SM; Koeck T; Campbell A; Kuznetsova T; Mischak H; Padmanabhan S; Dominiczak AF; Delles C; Staessen JA
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28784649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.
    Motiwala SR; Gaggin HK
    Curr Heart Fail Rep; 2016 Oct; 13(5):207-218. PubMed ID: 27726056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction.
    Rossing K; Bosselmann HS; Gustafsson F; Zhang ZY; Gu YM; Kuznetsova T; Nkuipou-Kenfack E; Mischak H; Staessen JA; Koeck T; Schou M
    PLoS One; 2016; 11(6):e0157167. PubMed ID: 27308822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carboxy-terminal telopeptide of type I collagen (I-CTP) is predictive of clinical outcome in peripheral artery disease patients following endovascular therapy.
    Otaki Y; Watanabe T; Takahashi H; Yamaura G; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Heart Vessels; 2017 Feb; 32(2):149-156. PubMed ID: 27251570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to chronic alcohol accelerates development of wall stress and eccentric remodeling in rats with volume overload.
    Mouton AJ; Ninh VK; El Hajj EC; El Hajj MC; Gilpin NW; Gardner JD
    J Mol Cell Cardiol; 2016 Aug; 97():15-23. PubMed ID: 27107489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure.
    Löfsjögård J; Kahan T; Díez J; López B; González A; Edner M; Henriksson P; Mejhert M; Persson H
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):463-9. PubMed ID: 24983265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure.
    Löfsjögård J; Persson H; Díez J; López B; González A; Edner M; Mejhert M; Kahan T
    Scand Cardiovasc J; 2014 Oct; 48(5):299-303. PubMed ID: 24978653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
    Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
    Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.